JPRN-UMIN000029308已完成未知
Study on efficacy and safety as well as on the changes in blood purine compounds by the treatment of patients with amyotrophic lateral sclerosis with febuxostat and inosine in combination. - Effect of febuxostat and inosine on amyotrophic lateral sclerosis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Subject who has or had hypersensitivity, idiosyncracy (allergy) to drug. 2.Subjects taking azathioprine or mercaptopurine 3.Subject who has or had renal function disorder. 4.Subject with a history of gout, hyperuricemia or urolithiasis. 5.Patients who changed therapeutic drugs and treatment methods within 1 month before administration of test drugs 6.Subject who was judged not to be appropriate by the principal investigator or sub investigators by other reasons.
研究者
相似试验
进行中（未招募）
不适用
A Study to Determine the Safety, Efficacy, and Pharmacokinetics of 80 mg, 160 mg, and 320 mg ALD518 versus Placebo Administered as Multiple Intravenous Infusions to Patients with Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate.Active Rheumatoid ArthritisMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2008-004931-39-PLAlder Biopharmaceuticals, Inc120
进行中（未招募）
1 期
A study to evaluate the efficacy, safety, and pharmacokinetics of IgPro20 in adults with dermatomyositis (DM)MedDRA version: 20.0Level: LLTClassification code 10001403Term: Adult dermatomyositisSystem Organ Class: 100000004858DermatomyositisEUCTR2018-003171-35-DECSL Behring LLC126
进行中（未招募）
1 期
A study to evaluate the efficacy, safety, and pharmacokinetics of IgPro20 in adults with dermatomyositis (DM)MedDRA version: 20.0Level: LLTClassification code 10001403Term: Adult dermatomyositisSystem Organ Class: 100000004858DermatomyositisEUCTR2018-003171-35-HUCSL Behring LLC126
进行中（未招募）
1 期
A study to evaluate the efficacy, safety, and pharmacokinetics of IgPro20 in adults with dermatomyositis (DM)MedDRA version: 20.0Level: LLTClassification code 10001403Term: Adult dermatomyositisSystem Organ Class: 100000004858DermatomyositisEUCTR2018-003171-35-ITCSL BEHRING GMBH126
已完成
3 期
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra®) in Adults with Dermatomyositis (DM) - The RECLAIIM Studymuscle disease1002839310014982dermatomyositisNL-OMON55228CSL Behring LLC